GE Launches $250m Healthymagination Fund for healthcare technology
27 October 2009
GE (NYSE: GE) has launched the “GE Healthymagination Fund”, a
new equity fund that will make investments in highly promising
healthcare technology companies.
The fund will invest in companies globally that have innovative
diagnostic, IT, and life sciences technologies aligned with the
strategic objectives of GE’s Healthymagination initiative. The fund will
also support healthcare companies developing innovative and unique
business models and services.
The formation of the fund is part of GE’s US$6 billion
Healthymagination initiative, a global commitment to deliver better
healthcare to more people at lower cost. The fund will target three
broad areas for investment:
- Broad-based diagnostics, including imaging, home health, patient
monitoring, molecular diagnostics, pathology, novel imaging agents
and other technologies for disease diagnosis.
- Healthcare information technology, including electronic medical
records, clinical information systems, healthcare information
exchanges and value-added data services.
- Life sciences, including tools for research and development in
biopharmaceuticals and stem cells, and technologies for
manufacturing of biopharmaceuticals and vaccines.
The fund will draw on capabilities from across GE Healthcare, GE
Capital and GE Global Research, and will have a global footprint.
“The creation of the GE Healthymagination Fund reaffirms our
commitment to innovation in healthcare to bring better health to more
people,” GE Chairman and CEO Jeffrey Immelt said.
"As GE works on solutions to healthcare’s biggest challenges, it is
vitally important that we support the development of companies with
promising technologies or business models that are aligned with our
strategy and have the potential to shape the future of healthcare.
This includes smarter processes and technologies that measurably
increase access to healthcare, reduce the cost of delivery and improve
quality. The Healthymagination Fund gives us an opportunity to work with
emerging companies to support their development, as well as provide them
access to our technology base and our global presence."
"GE is able to offer a unique proposition to promising healthcare
companies,” Immelt said. “In addition to providing growth capital and
investment expertise, through this fund we offer entrepreneurs the
opportunity to work directly with a global leader in healthcare
technology in areas of mutual interest."
For further information about the fund, visit